![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](tk5035contents.gif)
Acta Cryst. (2012). E68, o190 [ doi:10.1107/S1600536811054043 ]
Abstract: The crystal structure of the title co-crystal, 2C6H7N3O·C6H10O4, is a second polymorph, designated form II, of the co-crystal formed between the two molecules [Lemmerer et al. (2011). CrystEngComm, 13, 55-59]. The asymmetric unit comprises one molecule of nicotinic acid hydrazide, and one half-molecule of adipic acid (the entire molecule is completed by the application of a centre of inversion). In the crystal, molecules assemble into a three-dimensional network of hydrogen bonds, formed by three N-H
O hydrogen bonds and one O-HN hydrogen bond. The O-HN hydrogen bond formed between the carboxyl group and the pyridine ring is supported by a C-HO hydrogen bond.
Online 21 December 2011
Copyright © International Union of Crystallography
IUCr Webmaster